• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒细胞毒性T淋巴细胞(CTL)表位内的单个残基交换会改变蛋白酶体介导的降解,导致抗原呈递缺失。

A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

作者信息

Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengedë E, Kloetzel P M, Neefjes J, Koszinowski U, Melief C

机构信息

Department of Immunohematology, Academic Hospital Leiden, The Netherlands.

出版信息

Immunity. 1996 Aug;5(2):115-24. doi: 10.1016/s1074-7613(00)80488-4.

DOI:10.1016/s1074-7613(00)80488-4
PMID:8769475
Abstract

CTL epitope (KSPWFTTL) encoded by AKV/MCF type of murine leukemia virus (MuLV) differs from the sequence in Friend/Moloney/Rauscher (FMR) type in one residue (RSPWFTTL). CTL experiments indicated defective processing of the FMR peptide in tumor cells. Proteasome-mediated digestion of AKV/MCF-type 26-mer peptides resulted in the early generation and higher levels of epitope-containing fragments than digestion of FMR-type peptides, explained by prominent cleavage next to R in the FMR sequence. The fragments were identified as 10- and 11-mer peptides and were efficiently translocated by TAP. The naturally presented AKV/MCF peptide is the 8-mer, indicating ER peptide trimming. In conclusion, a single residue exchange can cause CTL epitope destruction by specific proteasomal cleavage.

摘要

由AKV/MCF型鼠白血病病毒(MuLV)编码的CTL表位(KSPWFTTL)与Friend/Moloney/Rauscher(FMR)型的序列在一个残基上不同(RSPWFTTL)。CTL实验表明肿瘤细胞中FMR肽的加工存在缺陷。蛋白酶体介导的AKV/MCF型26聚体肽消化比FMR型肽消化产生表位含片段的时间更早且水平更高,这是由于FMR序列中R旁边的显著切割所致。这些片段被鉴定为10聚体和11聚体肽,并被TAP有效转运。天然呈现的AKV/MCF肽是8聚体,表明存在内质网肽修剪。总之,单个残基交换可通过特定的蛋白酶体切割导致CTL表位破坏。

相似文献

1
A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.病毒细胞毒性T淋巴细胞(CTL)表位内的单个残基交换会改变蛋白酶体介导的降解,导致抗原呈递缺失。
Immunity. 1996 Aug;5(2):115-24. doi: 10.1016/s1074-7613(00)80488-4.
2
Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.通过C末端蛋白酶体切割位点侧翼的单个氨基酸取代消除CTL表位加工。
J Immunol. 2000 Feb 15;164(4):1898-905. doi: 10.4049/jimmunol.164.4.1898.
3
Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.通过其MHC I类结合基序鉴定出的免疫显性水貂细胞灶诱导型鼠白血病病毒(MuLV)编码的CTL表位,解释了针对MCF的细胞毒性T淋巴细胞的MuLV类型特异性。
J Immunol. 1994 Jan 1;152(1):106-16.
4
A single amino acid variation within an immunodominant AKR/Gross MuLV cytotoxic T-lymphocyte epitope leads to a loss in immunogenicity.免疫显性AKR/Gross小鼠白血病病毒细胞毒性T淋巴细胞表位内的单个氨基酸变异导致免疫原性丧失。
Viral Immunol. 1998;11(4):197-213. doi: 10.1089/vim.1998.11.197.
5
Naturally occurring TAP-dependent specific T-cell tolerance for a variant of an immunodominant retroviral cytotoxic T-lymphocyte epitope.针对免疫显性逆转录病毒细胞毒性T淋巴细胞表位变体的天然存在的TAP依赖性特异性T细胞耐受性。
J Virol. 2000 Apr;74(8):3924-8. doi: 10.1128/jvi.74.8.3924-3928.2000.
6
An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.一种来自内源性嗜亲性鼠白血病病毒(MuLV)AKR623的p15E跨膜蛋白的免疫显性Kb限制性肽,该肽可恢复肿瘤细胞系对抗AKR/格罗斯MuLV细胞毒性T淋巴细胞的敏感性。
J Virol. 1994 Feb;68(2):897-904. doi: 10.1128/JVI.68.2.897-904.1994.
7
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
8
Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.金属肽酶和蛋白酶体的顺序切割参与了HIV-1包膜蛋白表位的加工,以进行内源性MHC I类抗原呈递。
J Immunol. 2000 May 15;164(10):5070-7. doi: 10.4049/jimmunol.164.10.5070.
9
Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.鉴定一种由H-2 Kb呈递的莫洛尼鼠白血病病毒细胞毒性T淋巴细胞表位,该表位在H-2 Db突变体bm13小鼠中表现出增强的识别能力。
J Virol. 1994 Sep;68(9):6038-46. doi: 10.1128/JVI.68.9.6038-6046.1994.
10
Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.免疫蛋白酶体下调淋巴细胞性脉络丛脑膜炎病毒中一个隐性T细胞表位的呈递。
J Immunol. 2004 Sep 15;173(6):3925-34. doi: 10.4049/jimmunol.173.6.3925.

引用本文的文献

1
Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven.免疫信息学分析揭示 EBV 免疫驱动的抗原异质性。
Front Immunol. 2021 Dec 16;12:796379. doi: 10.3389/fimmu.2021.796379. eCollection 2021.
2
IFN-γ treatment protocol for MHC-I/PD-L1 pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential.IFN-γ 治疗方案可选择性恢复 MHC-I/PD-L1 阳性胰腺肿瘤细胞的 TAP 介导递呈能力及其 CD8+T 细胞的初始激活潜能。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-000692.
3
Cell surface processing of the P1 adhesin of Mycoplasma pneumoniae identifies novel domains that bind host molecules.
肺炎支原体 P1 黏附素的细胞表面加工鉴定出与宿主分子结合的新结构域。
Sci Rep. 2020 Apr 14;10(1):6384. doi: 10.1038/s41598-020-63136-y.
4
Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.EB 病毒株的异质性损害人类 T 细胞免疫。
Cancer Immunol Immunother. 2018 Apr;67(4):663-674. doi: 10.1007/s00262-018-2118-z. Epub 2018 Jan 27.
5
Present Yourself! By MHC Class I and MHC Class II Molecules.自我展示!由MHC I类分子和MHC II类分子完成。
Trends Immunol. 2016 Nov;37(11):724-737. doi: 10.1016/j.it.2016.08.010. Epub 2016 Sep 7.
6
Optimizing T-cell receptor gene therapy for hematologic malignancies.优化用于血液系统恶性肿瘤的T细胞受体基因疗法。
Blood. 2016 Jun 30;127(26):3305-11. doi: 10.1182/blood-2015-11-629071. Epub 2016 May 20.
7
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.丙型肝炎病毒交叉反应性TCR基因修饰的T细胞:针对基因组不稳定疾病的免疫治疗模型。
J Leukoc Biol. 2016 Sep;100(3):545-57. doi: 10.1189/jlb.2A1215-561R. Epub 2016 Feb 26.
8
The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing.HLA-a*02:01 gp100表位中的T210M替换强烈影响整体蛋白酶体切割位点的使用及抗原加工。
J Biol Chem. 2015 Dec 18;290(51):30417-28. doi: 10.1074/jbc.M115.695189. Epub 2015 Oct 27.
9
Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.基于蛋白酶体体外消化和 MHC I 配体数据的切割位点计算预测。
J Zhejiang Univ Sci B. 2013 Sep;14(9):816-28. doi: 10.1631/jzus.B1200299.
10
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals.氨肽酶底物偏好影响 HIV 表位呈递,并预测 HIV 感染个体中的免疫逃逸模式。
J Immunol. 2012 Jun 15;188(12):5924-34. doi: 10.4049/jimmunol.1200219. Epub 2012 May 14.